Commercially-viable manufacturing for patient-specific cell therapies involves overcoming many different challenges for deliverability, quality, and sustainability. Many cell therapy developers underestimate these challenges, which can lead to problems later on in the development process.
To help you anticipate these challenges and get a rough idea of where you are on the path to commercial cell therapy manufacturing readiness, the PCT team has created a commercial manufacturing checklist for cell therapy developers.
This checklist can help you perform a self-assessment of your manufacturing process so you can make improvements.
Download your checklist now by filling out the form on this page!